Druszczynska Magdalena, Wlodarczyk Marcin, Janiszewska-Drobinska Beata, Kielnierowski Grzegorz, Zawadzka Joanna, Kowalewicz-Kulbat Magdalena, Fol Marek, Szpakowski Piotr, Rudnicka Karolina, Chmiela Magdalena, Rudnicka Wieslawa
Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland.
Clin Dev Immunol. 2013;2013:851452. doi: 10.1155/2013/851452. Epub 2013 Jan 20.
The mechanisms that promote either resistance or susceptibility to TB disease remain insufficiently understood. Our aim was to compare the expression of cell signaling transduction receptors, CD14, TLR2, CD206, and β2 integrin LFA-1 on monocytes from patients with active TB or nonmycobacterial lung disease and healthy individuals with M.tb latency and uninfected controls to explain the background of the differences between clinical and subclinical forms of M.tb infection. A simultaneous increase in the expression of the membrane bound mCD14 receptor and LFA-1 integrin in patients with active TB may be considered a prodrome of breaking immune control by M.tb bacilli in subjects with the latent TB and absence of clinical symptoms.
促进结核病耐药或易感性的机制仍未得到充分了解。我们的目的是比较活动性结核病患者、非分枝杆菌性肺病患者以及具有结核分枝杆菌潜伏感染的健康个体和未感染对照者单核细胞上细胞信号转导受体CD14、TLR2、CD206和β2整合素LFA-1的表达,以解释结核分枝杆菌感染临床和亚临床形式差异的背景。活动性结核病患者中膜结合型mCD14受体和LFA-1整合素表达的同时增加,可能被认为是潜伏性结核病且无临床症状的受试者中结核分枝杆菌突破免疫控制的前驱症状。